Header Logo

Connection

CHAD CREIGHTON to Piperazines

Back to Details
This is a "connection" page, showing publications CHAD CREIGHTON has written about Piperazines.
CHAD CREIGHTON
Connection Strength
0.026
Piperazines
  1. SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma. Clin Cancer Res. 2016 Mar 01; 22(5):1150-60.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.